|
European Medicines Agency EMA
(2021)
CC
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
|
|
|
Harding-Zentrum für Risikokompetenz; Robert-Koch-Instiut RKI
(2021)
C1
|
|
|
African Union; Africa CDC Centres for Disease Control and Prevention; World Health Organization WHO, et al.
(2021)
C1
AstraZeneca-SKBio in South Korea and Serum Institute of India
|
|
|
Robert-Koch-Institut RKI
(2021)
C1
INFO Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019)–mit mRNA-Impfstoffen –
Erklärung für die Formulare
|
|
|
Robert-Koch-Institut RKI
(2021)
C1
INFO Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019)–mit Vektor-Impfstoff –
|
|
|
Robert-Koch-Institut RKI
(2021)
CC
|
|
|
World Health Organization WHO
(2021)
C_WHO
|
|
|
African Union; Africa CDC Centres for Disease Control and Prevention
(2021)
C1
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
|
|
|
Dirección de Control de Enfermedades Inmunoprevenibles
Ministerio de Salud Argentina
(2021)
CC
Vaccinator's Manual. MODERNA Vaccine
|
|
|
Dirección de Control de Enfermedades Inmunoprevenibles
Ministerio de Salud Argentina
(2021)
CC
Vaccinator's Manual. Pfizer-BioNTech Comirnaty Vaccine
|
|